نتایج جستجو برای: 221 and 334 percent

تعداد نتایج: 16830352  

Journal: :Heart 2009
Kim Rajappan

These include: Data supplement http://heart.bmj.com/cgi/content/full/95/4/334/DC1 "Education module notice" References http://heart.bmj.com/cgi/content/full/95/4/334#BIBL This article cites 7 articles, 3 of which can be accessed free at: Rapid responses http://heart.bmj.com/cgi/eletter-submit/95/4/334 You can respond to this article at: service Email alerting the top right corner of the article...

2013
Laura Lupini Cristian Bassi Manuela Ferracin Nenad Bartonicek Lucilla D'Abundo Barbara Zagatti Elisa Callegari Gentian Musa Farzaneh Moshiri Laura Gramantieri Fernando J. Corrales Anton J. Enright Silvia Sabbioni Massimo Negrini

microRNA miR-221 is frequently over-expressed in a variety of human neoplasms. Aim of this study was to identify new miR-221 gene targets to improve our understanding on the molecular tumor-promoting mechanisms affected by miR-221. Gene expression profiling of miR-221-transfected-SNU-398 cells was analyzed by the Sylamer algorithm to verify the enrichment of miR-221 targets among down-modulated...

2017
Xue Yang Ji-An Yang Bao-Hui Liu Jian-Ming Liao Fan-En Yuan Yin-Qiu Tan Qian-Xue Chen

Glioblastoma is the most common type of primary brain tumor in adults, with high mortality and morbidity rates. More effective therapeutic strategies are imperative. Previous studies have shown that the known p110-β-selective inhibitor TGX-221 blocks the activation of PKB/Akt in PTEN-deficient cells. We treated U87 and U251 glioblastoma cells with TGX-221 to determine the effect of TGX-221. We ...

2013
Maria Teresa Di Martino Annamaria Gullà Maria Eugenia Gallo Cantafio Marta Lionetti Emanuela Leone Nicola Amodio Pietro Hiram Guzzi Umberto Foresta Francesco Conforti Mario Cannataro Antonino Neri Antonio Giordano Pierosandro Tagliaferri Pierfrancesco Tassone

A rising body of evidence suggests that silencing microRNAs (miRNAs) with oncogenic potential may represent a successful therapeutic strategy for human cancer. We investigated the therapeutic activity of miR-221/222 inhibitors against human multiple myeloma (MM) cells. Enforced expression of miR-221/222 inhibitors triggered in vitro anti-proliferative effects and up-regulation of canonic miR-22...

2016
Lijie Zhou Fangfang Jiang Xijuan Chen Zifeng Liu Ying Ouyang Wei Zhao Dongsheng Yu

MicroRNA-221 and microRNA-222 (miR-221/222) have been identified as oncogenes and confirmed to be overexpressed in various types of cancer. However, the regulation mechanism of miR-221/222 in oral squamous cell carcinoma (OSCC) remains to be fully elucidated. Previously, an miR-221/222 sponge was successfully constructed and its effect on the downregulation of miR-221/222 expression was investi...

Journal: :International journal of clinical and experimental medicine 2015
Yiming Xu Chongjun Zhong Shengguang Ding Haitao Huang Zhenya Shen

MicroRNA (miRNA-221) has been reported to be a regulator of cell proliferation. Here we intended to investigate the role of miRNA-221 in regulating the growth of human non-small cell lung cancer cell line H460. H460 cells were transfected with miRNA-221 mimics/inhibitors or their respective negative controls. Real-time quantitative PCRs (qRT-PCRs) were used to confirm the effects of miRNA-221 m...

Journal: :Journal of Pain and Symptom Management 2012

Journal: :Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008
Hyun Joo Kim Young Ha Kim Dong Soo Lee June-Key Chung Soonhag Kim

UNLABELLED MicroRNAs (miRNAs) are small, noncoding RNA molecules that control expression of target genes. The abnormally expressed miRNAs function as oncogenes or tumor suppressors in human cancer. To evaluate the abundant gene regulation of miR-221 in papillary thyroid carcinoma (PTC), we performed microarray analysis and developed a Gaussia luciferase (Gluc) reporter system regulated by miR-2...

2015
Wendian Zhang Fangqi Peng Taotao Zhou Yifei Huang Li Zhang Peng Ye Miao Lu Guang Yang Yongkang Gai Tan Yang Xiang Ma Guangya Xiang

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death. Gene therapy was established as a new strategy for treating HCC. To explore the potential delivery system to support the gene therapy of HCC, negatively charged liposomal delivery system was used to deliver miR-221 antisense oligonucleotide (anti-miR-221) to the transferrin (Tf) receptor over expressed HepG2 ce...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید